Is human T-cell lymphotropic virus type I really silent?

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• The cellular immune response to human T-cell lymphotropic virus type I (HTLV-I) is not fully understood.
• HTLV-I is widely believed to be transcriptionally silent in vivo due to low observed protein expression in lymphocytes.
• Despite low expression, HTLV-I infected individuals exhibit a strong, persistent cytotoxic T-lymphocyte (CTL) response, suggesting active viral gene transcription.

Purpose of the Study:

• To investigate the dynamic interplay between HTLV-I protein expression and the CTL response in vivo.
• To reconcile the apparent transcriptional silence with the robust CTL response observed in HTLV-I infection.
• To determine the efficiency of CTL-mediated clearance of HTLV-I expressing cells.

Main Methods:

• Freshly isolated peripheral blood lymphocytes from HTLV-I infected individuals were analyzed for Tax protein expression.
• Kinetics of Tax protein expression and CTL-mediated cell killing were assessed.
• Mathematical modeling was employed to quantify the efficiency of the CTL response.

Main Results:

• HTLV-I Tax protein expression was found to increase rapidly in freshly isolated lymphocytes.
• Cells expressing Tax protein were efficiently and rapidly eliminated by CTLs.
• Mathematical analysis revealed an extremely efficient CTL response, with a half-life of less than a day for Tax-expressing cells.

Conclusions:

• The rapid clearance of HTLV-I Tax-expressing cells by CTLs explains the low, undetectable levels of viral protein in circulating lymphocytes.
• The cellular immune response, specifically CTL surveillance, plays a critical role in controlling HTLV-I transcription in vivo.
• Current detection methods may underestimate HTLV-I activity due to the high efficiency of the immune response.